Zoekresultaten - 18 results
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Dimitrijevic, Dragana; Druc, Alina; Apostol, Mariana; Kalasnikova, Kate Karolina; Nikisins, Sergejs; Reiche, Janine; Cai, Wei; Meijer, Adam; Teirlinck, Anne; Larrauri, Amparo; Casas, Inmaculada; Enouf, Vincent; ...
Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe.
Publication Type: Peer reviewed scientific article Authors: Dominik Stelzle; Annette Abraham; Miriam Kaminski; Veronika Schmidt; Robert De Meijere; Javier A Bustos; Hector Hugo Garcia; Priyadarshi ...
Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel.
Publication Type: Peer reviewed scientific article Authors: Polman, N J; Oštrbenk, A; Lan Xu; Snijders, P J F; Meijer, C J L M; Poljak, M; Heideman, D A M; M. Arbyn Source: J Clin Microbiol (2017) ...
Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14
Waters,A.; Wiman,A.; Meijer,A. Source: Euro.Surveill, Volume 21, Issue 41 (2016) Keywords: a age AGE GROUP AGE GROUPS Age-group ALL Area article Case composition Control Countries data Decision Decision Making ...
Correction for Geraets et al., Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control.
Publication Type: Peer reviewed scientific article Authors: Geraets, D T; Cuschieri, K; de Koning, M N C; van Doorn, L J; Snijders, P J F; Meijer, C J L M; Quint, W G V; M. Arbyn Source: J Clin ...
Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion.
Francesca; Del Mistro, Annarosa; de Sanjosé, Silvia; Bosch, Xavier; Petry, Karl Ulrich; Poljak, Mario; Naldoni, Carlo; Meijer, Chris J L M; Comparing Health Services Interventions for the Prevention of ...
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Snijders, P J F; Meijer, C J L M; Berkhof, J; Cuschieri, K; Kocjan, B J; Poljak, M Source: Clin Microbiol Infect, Volume 21, ...
Cervical cancer screening by human papillomavirus testing followed by cytology triage.
Publication Type: Peer reviewed scientific article Authors: Giorgi-Rossi, Paolo; M. Arbyn; Meijer, Chris J L M Source: JAMA Intern Med, Volume 175, Issue 6, p.1068 (2015) Keywords: ...
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Snijders, Peter J F; Meijer, C.J.L.M.; Berkhof, J; Cuschieri, K.; Kocjan, B.J.; Poljak, M Source: Clinical Microbiology and ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
Publication Type: Peer reviewed scientific article Authors: Geraets, D T; Cuschieri, K; de Koning, M N C; van Doorn, L J; Snijders, P J F; Meijer, C J L M; Quint, W G V; M. Arbyn Source: J Clin ...